The 5-Year Results and Correlative Analyses from TBCRC 033 was published in the Journal of Clinical Oncology
Publications
Additional correlative work from TBCRC 043 was published in Cancer Research Communications.
The results from TBCRC 057 were published in Cancer Medicine.
A correlative analysis from TBCRC 043 was published in Cancer Discovery.
The clinical results of TBCRC 043 were published in JAMA Oncology.
The results from TBCRC 039 were published in Breast Cancer Research.
The quality of life analysis from TBCRC 029 was published in Oncologist.
Additional clinical work from TBCRC 030 was published in Annals of Oncology.
The results from TBCRC 026 were published in the Journal of Nuclear Medicine.
Correlative analyses using samples from TBCRC 008 and 030 were published in Breast Cancer Research and Treatment.
The results from TBCRC 041 were published in JAMA Oncology
Correlative results from TBCRC 023 were published in Clinical Cancer Research
Correlative results from TBCRC 030 were published in Nature Genetics
The results from the Aurora Retrospective study were published in Nature Cancer
An analysis of TBCRC 038 was published in Cancer Cell
Treatment discontinuation, patient-reported toxicities, and quality of life results from TBCRC 033 were published in NPJ Breast Cancer
Local therapy outcomes and toxicity from TBCRC 033 were published in International Journal of Radiation Oncology, Biology, Physics
Cardiac outcome results from TBCRC 033 were published in NPJ Breast Cancer
The results from TBCRC 033 were published in the Journal of Clinical Oncology.
The results from TBCRC 036 were published in NPJ Breast Cancer.
The results from TBCRC 048 were published in the Journal of Clinical Oncology.
The results from TBCRC 034 were published in the Annals of Surgical Oncology.
The results from TBCRC 030 were published in the Annals of Oncology.
The results from TBCRC 015 were published in Breast Cancer Research and Treatment.
The results from TBCRC 031 were published in the Journal of Clinical Oncology.
The results from TBCRC 032 were published in Clinical Cancer Research.
Additional results from TBCRC 022 were published in Clinical Breast Cancer.
A paper summarizing the patient reported outcomes in TBCRC trials was published in Cancer.
The results from TBCRC 002 were published in Breast Cancer Research.
The results from TBCRC 023 were published in Clinical Cancer Research.
Correlative results from TBCRC 023 were published in Journal of the National Cancer Institute.
The results from TBCRC 006 and 023 were published in Annals of Oncology.
The results from TBCRC 030 were presented at the 2019 American Society of Clinical Oncology Annual Meeting.
The results from the additional cohorts of TBCRC 022 were published in the Journal of Clinical Oncology.
The results of TBCRC 026 were published in the Journal of Clinical Oncology.
A biomarker analysis of TBCRC 024 was presented at the 2018 American Society for Radiation Oncology Annual Meeting
The results from TBCRC 027 were published in NPJ Breast Cancer.
The results from TBCRC 024 were published in the Journal of Clinical Oncology.
A retrospective characterization of male breast cancer was published in the Annals of Oncology.
TBCRC 006 correlative study results were published in Breast Cancer Research and Treatment.
TBCRC 008 correlative study results were published in Breast Cancer Research and Treatment.
A pathologic characterization of male breast cancer, through retrospective tissue collection, was published in the European Journal of Cancer.
The TBCRC 005 prospective biomarker study results were published in the Journal of Clinical Oncology.
The results of TBCRC 010 were published in Clinical Cancer Research.
The TBCRC 013 results were published in the Journal of Clinical Oncology.
The results of TBCRC 013 were presented at the 2016 American Society of Clinical Oncology (ASCO) Meeting.
The TBCRC 015 results were published in Oncotarget.
The TBCRC 020 results were published in the Annals of Surgical Oncology.
The TBCRC 022 results from one arm of the trial were published in the Journal of Clinical Oncology.
The TBCRC 009 results were published in the Journal of Clinical Oncology.
The TBCRC 019 clinical trial results and the circulating tumor cell analyses were published in Clinical Cancer Research.
Additional results from TBCRC 017 were published in the Annals of Surgical Oncology.
The results of the TBCRC 001 circulating tumor cell analysis were published in Clinical Cancer Research.
The TBCRC 008 results were published in the Journal of Nuclear Medicine.
The TBCRC 007 results were published in Breast Cancer Research and Treatment.
The results from TBCRC 018 were published in Breast Cancer Research and Treatment.
Results of a novel blood test (using specimens from TBCRC 005 and 013) that monitors treatment response and/or breast recurrence were published in Cancer Research. A news release describing this publication is also available.
The results from TBCRC 011 were published in Clinical Cancer Research.
The results from TBCRC 017 were published in Cancer.
The results from TBCRC 006 were published in the Journal of Clinical Oncology.
Presentations
TBCRC 034 will be presented at the SSO 2024 Annual Meeting.
The Translational Breast Cancer Research Consortium was well represented at the 2023 San Antonio Breast Cancer Symposium (SABCS). Click here for a summary of the trials presented.
TBCRC 026 will be presented at the 2023 ESMO Congress.
The Translational Breast Cancer Research Consortium was well represented at the 2022 San Antonio Breast Cancer Symposium. Click here for a summary of the trials presented.
TBCRC 026 was presented at the 2022 ESMO Congress.
The Aurora Retrospective Trial was presented at the 2022 Metastatic Breast Cancer Research Conference.
The Translational Breast Cancer Research Consortium had two presentations at the 2022 ASCO Meeting. Click here for links to the abstracts.
The Aurora Retrospective Trial was presented at the 2022 American Association for Cancer Research (AACR) Annual Meeting.
The Translational Breast Cancer Research Consortium was well represented at the 2021 San Antonio Breast Cancer Symposium. Click here for a summary of the trials presented.
The local therapy outcomes and toxicity from TBCRC 033 will be presented at the 2021 American Society for Radiation Oncology (ASTRO).
TBCRC 033 was presented at the 2021 American Society for Radiation Oncology (ASTRO) Annual Meeting.
The Translational Breast Cancer Research Consortium was well represented at the 2021 ASCO Meeting. Click here for links to the abstracts.
The Translational Breast Cancer Research Consortium was well represented at the 2020 San Antonio Breast Cancer Symposium. Click here for links to the abstracts.
TBCRC 049 was presented at the 2020 Society for NeuroOncology Virtual Meeting.
The Translational Breast Cancer Research Consortium was well represented at the 2020 ASCO Meeting. Click here for links to the abstracts.
The Translational Breast Cancer Research Consortium was well represented at the 2020 ASCO Meeting. Click here for links to the abstracts.
The Translational Breast Cancer Research Consortium was well represented at the 2019 San Antonio Breast Cancer Symposium. Click here for links to the abstracts.
The results of TBCRC 035 were presented at the 2019 American Association of Cancer Research (AACR) Annual Meeting.
The results of TBCRC 034 were presented at the 2019 Society of Surgical Oncology (SSO) Annual Cancer Symposium.
The Translational Breast Cancer Research Consortium was well represented at the 2018 San Antonio Breast Cancer Symposium. Click here for links to the abstracts
An imaging prognostic biomarker from TBCRC 026 was presented at the 2018 World Molecular Imaging Congress
The Translational Breast Cancer Research Consortium was well represented at the 2018 ASCO Meeting. Click here for links to the abstracts
The Translational Breast Cancer Research Consortium was well represented at the 2017 San Antonio Breast Cancer Symposium. Click here for links to the abstracts
The Translational Breast Cancer Research Consortium had two presentations at the 2017 American Society of Clinical Oncology (ASCO) Meeting. Click here for links to the presentations.
The correlative results of TBCRC 008 were presented at the 2016 San Antonio Breast Cancer Symposium. Click here for links to the abstracts.
The registry results of TBCRC 013 were presented at the 2016 American Society of Breast Surgeons Annual Meeting.
The Translational Breast Cancer Research Consortium had several presentations at the 2015 San Antonio Breast Cancer Symposium. Click here for links to the presentations.
The Translational Breast Cancer Research Consortium was well represented at the 2015 American Society of Clinical Oncology (ASCO) Meeting. Click here for links to the presentations.
The results of TBCRC 020 were presented at the 2015 Society of Surgical Oncology Annual Cancer Symposium.
The Translational Breast Cancer Research Consortium had several presentations at the 2014 San Antonio Breast Cancer Symposium. Click here for links to the presentations.
The Translational Breast Cancer Research Consortium was well represented at the 2014 American Society of Clinical Oncology (ASCO) Click here for links to the presentations.
The Translational Breast Cancer Research Consortium had several presentations at the 2013 San Antonio Breast Cancer Symposium. Click here for links to the presentations.
The Translational Breast Cancer Research Consortium was well represented at the 2013 American Society of Clinical Oncology (ASCO) Meeting. Click here for links to the presentations.
Other TBCRC Activities
A summary of the 2023 TBCRC Presentations and Publications is available by clicking here.
A summary of the 2022 TBCRC Presentations and Publications is available by clicking here.
A summary of the 2021 TBCRC Presentations and Publications is available by clicking here.
A summary of the 2020 TBCRC Presentations and Publications is available by clicking here.
A summary of the 2019 TBCRC Presentations and Publications is available by clicking here.
A summary of the 2018 TBCRC Presentations and Publications is available by clicking here.